The deadline day of this Winter Transfer Window saw a triple transfer in which Michy Batshuayi moved to Borussia Dortmund, Pierre-Emerick Aubameyang moved to the Emirates while Olivier Giroud joined the Blues. In this merry-go-round every team has got profit as Batshuayi is scoring for Dortmund while Aubameyang and Giroud also opened their goalscoring tally for their respective clubs.
Our spotlight will be on Giroud to Chelsea. Arsenal has already got a big depth in their attack and when they brought in Aubameyang, they were sure of letting go of any one striker, Giroud being one of the best choices for them.
Chelsea were looking for a Premier League proven striker by the end of the window due to the injury concerns of Alvaro Morata. The West London side were heavily linked with the likes of Tony Carroll, Peter Crouch and Ashley Barnes. Carroll to Chelsea looked likely to happen but then the player got injured shattering any possibility of the transfer. Giroud being a proven goalscorer for Arsenal came under Chelsea’s radar from then. However, Arsenal was not ready then to sell Giroud as they could not confirm the Aubameyang signing till then. Chelsea foreseen a possible tripple transfer and listed Batshuayi on loan.
After a long wait it happened as Dortmund did not want to let go off their star striker.
Who benefits the most in the deal Chelsea or Arsenal?
It is a very difficult ask provided how proven goalscorer Giroud is. He has scored more than 100 goals in the Premier League and Chelsea needed someone experienced. It was seen as a result as the Frenchman not only scored his first goal against Hull but also assisted twice. Thus, for a short term transfer Chelsea can be called the winners. However, from Arsenal’s viewpoint it is a very good deal to as Giroud was surplus to their requirements and getting £15.30m for a 31 year old is commendable. Thus we declare Arsenal as the winners here. No offence to Chelsea fans as Giroud can prove to be an exceptional signing for them but Arsenal got the profit from the deal.